Hey there! Welcome!
Get updated on
ERS 2026_CH web banner-01
ERS 2026_CH web banner-02
ERS 2026_CH web banner-02
Top Picks

calendar
18 Nov, 26
HF & CKD are interlinked; ESC 2026 CVD-CKD Guidelines focus on the need of integrated management of CVD-CKD. Routine eGFR/UACR screening, GDMT & proactive hyperkalemia management may improve survival, cut hospitalizations, & preserve renal function.

calendar
13 Nov, 26
dot
link
AHA 2026
The sessions presented at AHA 2026, underscore the importance of secondary prevention in MI patients and focus on the benefits of beta-blocker treatment and reperfusion treatment in these patients.

calendar
20 Nov, 26
dot
link
Diabetes Care.
  • The UK CF Registry analysis included 4,477 CF-related diabetes patients (31,311 person-yrs of follow-up, & 758 deaths)
  • Compared with HbA1c ≤42 mmol/mol, adjusted mortality rate ratios were 1.41 for >42–53 mmol/mol, 1.66 for >53–69 mmol/mol, & 1.93 for >69 mmol/mol
  • Higher long-term HbA1c was associated with a progressive, clinically significant increase in mortality risk in CF-related diabetes.

calendar
20 Nov, 26
dot
link
Int Dent J.
  • In a meta-analysis of 30 studies (2,476 BMS patients; 2,417 controls), burning mouth syndrome (BMS) was associated with significantly higher anxiety (SMD 1.12), depression (SMD 1.12), & sleep disturbance (SMD 0.97; all p<0.001)
  • OHRQoL was also markedly impaired (MD 16.04; p<0.001)
  • Findings support multidisciplinary management of both pain & psychological comorbidities.

calendar
19 Nov, 26
dot
link
Diabetes Obes Metab.
  • Amongst 833 adults with hypertension (HTN) &/or diabetes (DM), attending tertiary clinic in India, clinical obesity was prevalent in 70.7%, highest in HTN alone (88%)
  • BMI & Conicity Index were significantly elevated (p<0.001), age 60-69 yrs, extended family status, HTN >10 yrs, tobacco use, & coexisting HTN+DM independently increased obesity risk (p<0.001)
  • Sensitivity analysis estimated obesity prevalence at 50%

calendar
17 Nov, 26
dot
link
Eur J Prev Cardiol.
  • Elevated remnant cholesterol [≥1 mmol/L (39 mg/dL)] was more prevalent in familial hypercholesterolemia (FH) population (12%-78%) vs non-FH individuals (11%-12%)
  • Across CGPS & UK Biobank, remnant cholesterol ≥1 mmol/L was associated with higher CAD risk in FH (HRs 1.14-1.60) & non-FH subjects (HR 1.47-1.49), conferring an approximately 50% additional CAD risk beyond lifelong LDL-C elevation in FH individuals.